2017 HIV supportive medicine list (formulary)
|
|
|
- Sara Porter
- 6 years ago
- Views:
Transcription
1 2017 HIV supportive medicine list (formulary)
2 This document lists the supportive medicines that are on the medicine list (formulary) of the HIVCare Programme for Disclaimer The information contained in this document is subject to change. The HIVCare Programme is governed by Netcare Medical Scheme Rules, administered by Discovery Health (Pty) Ltd. The utilisation of the benefits and programmes associated with the HIVCare Programme is subject to specific conditions and rules. Members must ensure that they are familiar with these rules and conditions. Any instructions or advice on medicines and the management of the member s condition are intended as a supplement to, and not a substitute for, the knowledge, expertise, skill and judgement of the member s doctor, pharmacist or other healthcare professional. Netcare Medical Scheme reserves the right to change how we cover treatment on the programme at any time. About some of the terms we use in this document There may be some terms we refer to in the document that you may not be familiar with. Here are the meanings of these terms. Terminology Benefit year NAPPI Code Description A benefit year refers to the benefits a member is entitled to during a calendar year, that is to say 1 January to 31 December. This medicine list (formulary) and the Chronic Drug Amounts are applicable for 2017 only. This is a unique identifier for a given medicine, surgical or consumable product.
3 HIV supportive medicine list (formulary) Condition Fungal Apex-fluconazole 200mg CAP Fungal Flucoric 200mg CAP Fungal Zydus fluconazole 200mg CAP Fungal Insep 200mg CAP Fungal Sandoz ketoconazole 200mg TAB Fungal Gulf fluconazole 200mg CAP Fungal Auro fluconazole 200mg CAP Fungal Candacide u/1mL SUS Fungal Canstat oral SUS Fungal Nystacid SUS HIV-related Infections Lovire 200mg DSP HIV - Related Infections Adco-acyclovir 200mg TAB HIV-related Infections Acitab-200 dt 200mg DSP HIV-related Infections Acyclovir biotech 200mg TAB HIV-related Infections Lovire 400mg DSP HIV-related Infections Acitab-400 dt 400mg DSP HIV-related Infections Cyclivex 400mg TAB HIV-related Infections Apex-acyclovir 400mg TAB HIV-related Infections Aciclovir sandoz 400mg TAB HIV-related Infections Benzathinepen 1,2mufresenius HIV-related Benzathinepen 2,4mufresenius HIV-related Triaphin vial 15ml 1g HIV-related Adco ceftriaxone powder for 1g injection HIV-related Rociject-powder for injection 1g HIV-related Gulf ceftriaxone powder for 1g injection HIV-related Triaphin vial 5ml 250mg HIV-related Cpl alliance ciprofloxacin 500mg TAB HIV-related Biotech ciprofloxacin 500mg TAB
4 Condition HIV-related Cifran mg TAB HIV-related Ciprogen 500mg TAB HIV-related Loxip 500mg TAB HIV-related Ciprol 500mg TAB HIV-related Flopro 500mg TAB HIV-related Canex vag 1% VCR HIV-related Fungispor (1 applicator) VCR HIV-related Gyno pevaryl 150mg VAT HIV-related Xeramel 250mg CAP HIV-related Purmycin 250mg CAP HIV-related Eryko 250mg TAB HIV-related Adco-erythromycin 250mg CAP HIV-related Amzole 400mg TAB HIV-related Suprazole 400mg TAB HIV-related Bemetrazole 400mg TAB HIV-related Anaerobyl 400mg TAB HIV-related Bio-metronidazole 400mg TAB HIV-related Metazol 400mg TAB HIV-related Nucotet 250mg CAP HIV-related Pharmatet (yellow/orange) 250mg CAP HIV-related Novocillin 10ml 300mg/1mL HIV-related Novocillin 20ml 300mg/1mL HIV-related Clarihexal 500mg TAB HIV-related Co-trim SUS HIV-related Ilvitrim SUS HIV-related Xerazole SUS HIV-related Doctrim SUS HIV-related Purbac SUS HIV-related Ilvitrim TAB HIV-related Nucotrim TAB HIV-related Trixazole 480mg TAB HIV-related Lagatrim 480mg TAB HIV-related Trimethox TAB HIV-related Sandoz co-trimoxazole 800mg/160mg TAB
5 Condition HIV-related Purbac ds 960mg TAB HIV-related Durobac 'ds' 960mg TAB HIV-related Klarithran 500mg TAB HIV-related Klarizon 500mg TAB HIV-related Klaryvid 500mg TAB HIV-related Klaribin 500mg TAB HIV-related Mylan clarithromycin 500mg TAB Peripheral neuropathy Sandoz amitriptyline 25mg TAB Peripheral neuropathy Gulf amitriptyline 25mg TAB Peripheral neuropathy Trepiline 25mg TAB Peripheral neuropathy Zeptol 200mg TAB Peripheral neuropathy Pyridoxine 25mg TAB Peripheral neuropathy Pyridoxine 25mg TAB Peripheral neuropathy Be-tabs pyridoxine hcl 25mg TAB Dapsone 100mg TAB Winthrop isoniazid 100mg TAB Ebsar 2-ds 300/150 TAB Rifinah 150mg/75mg TAB Pyrazide 500mg TAB Rifinah 150/ mg;150mg TAB Antib-4 TAB
6 Condition Rimactane 150mg CAP Complaints process You may lodge a complaint or query with Netcare Medical Scheme directly on or address a complaint in writing to the Principal Officer at the Scheme s registered address. Should your complaint remain unresolved, you may lodge a formal dispute by following the Netcare Medical Scheme internal disputes process. You may, as a last resort, approach the Council for Medical Schemes for assistance. Their contact details are as follows: Council for Medical Schemes Complaints Unit, Block A, Eco Glades 2 Office Park, 420 Witch- Hazel Avenue, Eco Park, Centurion, 0157 / / complaints@medicalschemes.com/
WitsMed: HIV Supportive Formulary 2017
WitsMed: HIV Supportive Formulary 2017 Who we are WitsMed (referred to as the Scheme ), registration number 1282, is the medical scheme that you are a member of. This is a non-profit organisation, registered
HIVCare Programme 2017
HIVCare Programme 2017 Who we are LA Health Medical Scheme (referred to as 'the Scheme"), registration number 1145, is a non-profit organisation, registered with the Council for Medical Schemes. Discovery
CYSTIC FIBROSIS. Pace4 Pace3 Pace2 A AMOXYCILLIN ADCO-AMOX 125MG SUSP YES ADCO-AMOX 500MG CAP ADCO-AMOX 250MG SUSP A-LENNON AMOXYCILLIN 250M
Benefits are subject to the following: Pre-authorisation Bestmed guidelines Bestmed protocols Mediscor Reference Price (MRP) This price represents the reasonable price in the market place for a particular
HIV Programme. Overview. About some of the terms we use in this document
HIV Programme Overview This document gives you information about the Bankmed HIV Programme. It explains your cover for hospital admissions related to HIV and AIDS and how we pay for HIV medication. We
Oncology Programme 2017
Oncology Programme 2017 Who we are Remedi Medical Aid Scheme (referred to as 'the Scheme"), registration number 1430, is a non-profit organisation, registered with the Council for Medical Schemes. Discovery
Oncology Benefit 2018
Oncology Benefit 2018 Who we are LA Health Medical Scheme (referred to as the Scheme ), registration number 1145, is a non-profit organisation, registered with the Council for Medical Schemes. Discovery
Dental and Oral Benefit
Dental and Oral Benefit - 2018 Who we are The Malcor Medical Aid Scheme (referred to as the Scheme ), registration number 1547, is the medical scheme that you are a member of. This is a non-profit organisation,
Cover for MRI and CT scans
Cover for MRI and CT scans 2018 Overview An MRI (magnetic resonance imaging) scan produces detailed two- or three-dimensional images of organs inside the body, for example the spine or brain. A CT (computed
Dental and Oral Benefit 2018
Dental and Oral Benefit 2018 Who we are Remedi Medical Aid Scheme (referred to as 'the Scheme"), registration number 1430, is a non-profit organisation, registered with the Council for Medical Schemes.
Copyright Mediscor PBM (Pty) Ltd. This document is the property of Mediscor PBM (Pty) Ltd. Unauthorised use and distribution is prohibited.
Publication Date : 2014-07-30 Page 1 700315001 IBUCINE SUSP IBUPROFEN SUSP 100 MG/5ML ANALGESIC AND ANTIPYRETICS Y N Y 704781001 IBUGESIC 100MG/5ML SUSP IBUPROFEN SUSP 100 MG/5ML ANALGESIC AND ANTIPYRETICS
Oncology supportive medicine list formulary
Oncology supportive medicine list formulary Disclaimer The Bankmed Special Care Oncology Programme is governed by the Bankmed Medical Scheme Rules. The use of the benefits and programmes associated with
Oncology supportive medicine list (formulary) 2016
Oncology supportive medicine list (formulary) 2016 Who we are Glencore Medical Scheme (referred to as 'the Scheme"), registration number 1253, is a non-profit organisation, registered with the Council
Oncology Programme 2017
Oncology Programme 2017 Your cover for cancer treatment in 2017 Overview This document explains how Discovery Health Medical Scheme the Scheme covers you for cancer treatment on DiscoveryCare s Oncology
Prescribed Minimum Benefit Treatment Baskets 2018
Prescribed Minimum Benefit Treatment Baskets 08 Who are Glencore Medical Scheme (referred to as 'the Scheme"), registration number 5, is a non-profit organisation, registered with the Council for Medical
Prescribed Minimum Benefit Treatment Baskets for Chronic Disease Baskets of Care 2018
Prescribed Minimum Benefit Treatment Baskets for Chronic Disease Baskets of Care 08 Who we are SAB Medical Aid (the Scheme), registration number 09, is the medical scheme. This is a nonprofit organisation,
Prescribed Minimum Benefit Treatment Baskets- 2018
Prescribed Minimum Benefit Treatment Baskets- 08 Who we are The Malcor Medical Aid Scheme (referred to as the Scheme ), registration number 57, is the medical scheme that you a member of. This is a non-profit
Cover for dental treatment
Cover for dental treatment 2018 Overview This document explains the cover for dental treatment. It gives you details about how Discovery Health Medical Scheme defines and pays for dental treatment both
We will only fund Prescribed Minimum Benefit claims should your condition be approved on the Chronic Illness Benefit
Treatment Baskets for CDL 08 Overview The Prescribed Minimum Benefit Chronic Disease List is a list of conditions which all medical schemes need to on all the plans they offer to their members. This includes
Prescribed Minimum Benefit Treatment Baskets 2018
Prescribed Minimum Benefit Treatment Baskets 08 Who we are LA Health Medical Scheme (referred to as 'the Scheme ), registration number 5, is a non-profit organisation, registered with the Council for Medical
Treatment baskets for the Prescribed Minimum Benefit Chronic Disease List conditions
Treatment baskets for the Prescribed Minimum Benefit Chronic Disease List conditions 08 Treatment baskets for the Prescribed Minimum Benefit Chronic Disease List conditions Overview The Prescribed Minimum
MEDICINES CONTROL COUNCIL
MEDICINES CONTROL COUNCIL NOTIFICATION OF REGISTRATION OF MEDICINES BY THE REGISTRAR IN TERMS OF SECTION 17 OF THE MEDICINES AND RELATED SUBSTANCES ACT 101 OF 1965 Application Number Holder of registration
acute medicine formulary 2013
medihelp necesse acute medicine formulary 2013 January 2013 version 1.2013 Medihelp s Necesse acute medicine formulary Dear Doctor/Pharmacist Medihelp is pleased to present the latest updated version of
YES = formulary NO = non-formulary NO BENEFIT = excluded. Beat4 Beat1 Beat 3 Pace2 Beat2 Pace1 Pace3 Pace4 A NO BENEFIT SANDOZ AMITRIPTYLINE 25
Benefits are subject to the following: Pre-authorisation Bestmed guidelines Bestmed protocols Mediscor Reference Price (MRP) This price represents the reasonable price in the market place for a particular
1. Procedure for this Invitation to EOI. 2. Medicinal products included on the 14 th Invitation. Guidance Document 14 May 2016
To support national and global efforts to increase access to and the affordability of HIV/AIDS-related care and treatment together with UNICEF, UNAIDS and UNITAID, invite applicants for selected pharmaceutical
YES = formulary NO = non-formulary NO BENEFIT = excluded. Beat4 Beat1 Beat 3 Pace2 Beat2 Pace1 Pace3 Pace4 A NO BENEFIT SANDOZ AMITRIPTYLINE 25
Benefits are subject to the following: Pre-authorisation Bestmed guidelines Bestmed protocols Mediscor Reference Price (MRP) This price represents the reasonable price in the market place for a particular
5 Infections. To be used in conjunction with NICE guidance, The British National Formulary for adults and/or children and
5 Infections To be used in conjunction with NICE guidance, The British National Formulary for adults and/or children and Southend University Hospital, Antibiotic Guidelines Index 5.1 Antibacterial drugs
As a result of these reviews, Discovery Health has updated its Chronic Medicine Formulary and CDA.
Dear Pharmacist Update on the CDL formulary and Chronic Drug Amount for 2017 Discovery Health reviews the Chronic Medicine Formulary and Chronic Drug Amounts (CDAs) twice a year. We do this to make sure
Discovery HIVCare Programme
Discovery HIVCare Programme 2013 Discovery HIVCare Programme Overview This document gives you information about the Discovery HIVCare Programme. It explains your cover for HIV-and AIDS-related hospital
MEDICINES CONTROL COUNCIL
MEDICINES CONTROL COUNCIL NOTIFICATION OF REGISTRATION OF MEDICINES BY THE REGISTRAR IN TERMS OF SECTION 17 OF THE MEDICINES AND RELATED SUBSTANCES ACT, 1965 (ACT 101 OF 1965) 07/3.1.2.2/23 NOVARTIS SA
MRP Monthly Update MRP 12/2013
Monthly Update 12/2013 13/12/2013 Mediscor Reference Price - Notification Effective Date: 1 January 2014 Dear Vendors and Colleagues, The files for January 2014 are now available on our website: www.mediscor.net/mrp.html
ANTI COLD / ANTI ALLERGIC / ANTI-ASTHMATICS GIT PRODUCTS
SR. NO 1 ANTI COLD / ANTI ALLERGIC / ANTI-ASTHMATICS Paracetamol 500 mg, Phenylephrine HCL 5 mg With Chlorpheniramine Maleate 2 mg & Caffeine 30 mg Tablets 2 Salbutamol Tablets BP 2 mg 3 Salbutamol Tablets
Oncology Programme 2015
Oncology Programme 2015 Overview This document explains the University of KwaZulu-Natal Medical Scheme Oncology Programme for 2015 It gives you details about: What you need to do when you are diagnosed
MEDICINES CONTROL COUNCIL
Notification of of Medicines MEDICINES CONTROL COUNCIL NOTIFICATION OF REGISTRATION OF MEDICINES BY THE REGISTRAR IN TERMS OF SECTION 17 OF THE MEDICINES AND RELATED SUBSTANCES ACT, 1965 (ACT 101 OF 1965)
All Pharmacy and Prescribing Providers. Subject: State Maximum Allowable Cost (MAC) Updates
INDIANA HEALTH COVERAGE PROGRAMS P R O V I D E R B U L L E T I N B T 2 0 0 7 1 2 M A Y 2 9, 2 0 0 7 To: All Pharmacy and Prescribing Providers Subject: State Maximum Allowable Cost (MAC) Updates Effective
No. Description Packing UOM
Republic of the Philippines PITC Pharma, Inc. Bids and Awards Committee INVITATION TO BID VARIOUS GENERIC & ONCOLOGY MEDICINES, MEDICAL DEVICE & SUPPLIES (PROJECT REF. NO. BAC/GOODS 2016-02-002) The PITC
Home Delivery Prescription Program Drug List
Home Delivery Prescription Program Drug List Low-cost prescriptions, right in your mailbox. Now you can have your generic prescriptions mailed right to your home, no matter where you live. Because we think
Special Generic Drug Pricing Program
FREE PICK-UP & DELIVERY Flu-Shots Specialty prescription Compounding Wellness center providing health screenings for hypertension and diabetes $3 Special Generic Prescription Drug Program only offered
MEDICINES CONTROL COUNCIL
Notification of of Medicines MEDICINES CONTROL COUNCIL NOTIFICATION OF REGISTRATION OF MEDICINES BY THE REGISTRAR IN TERMS OF SECTION 17 OF THE MEDICINES AND RELATED SUBSTANCES ACT, 1965 (ACT 101 OF 1965)
Riesbeck's Pharmacy Reward Club Generic Medication List February 2018 $4 30 Day Supply
Allergy, Cold & Flu Antibiotic Treatments Arthritis & Pain Benzonatate 100mg cap 14 42 Diphenhydramine HCl Cap 50 MG 30 90 Diphenhydramine HCl Inj 50MG/ML 1 3 Diphenhydramine HCl Liquid 12.5 MG/5ML 720ml
APRIL Key Findings: Overall. Key Findings: Availability
APRIL 2006 Key Findings: Overall o Medicines were more available in private pharmacies than in other sectors o Even for medicines on the Kenya Essential Drug List, 20 out of 28 of these had below 50% availability
MEDICINES CONTROL COUNCIL
MEDICINES CONTROL COUNCIL NOTIFICATION OF REGISTRATION OF MEDICINES BY THE REGISTRAR IN TERMS OF SECTION 17 OF THE MEDICINES AND RELATED SUBSTANCES ACT, 1965 (ACT 101 OF 1965) 36/20.1.2/0204 BIOTECH 36/20.1.2/0205
MEDICINES CONTROL COUNCIL
Notification of of Medicines MEDICINES CONTROL COUNCIL NOTIFICATION OF REGISTRATION OF MEDICINES BY THE REGISTRAR IN TERMS OF SECTION 17 OF THE MEDICINES AND RELATED SUBSTANCES ACT, 1965 (ACT 101 OF 1965)
NB Drug Plans Formulary Update
Bulletin #984 October 31, 2018 NB Drug Formulary Update Drug product updates included in this bulletin: Drug product additions - New generic products will be reimbursed up to the category Maximum Allowable
ADCO-CAPTOPRIL 25MG BIO-CAPTOPRIL 25MG MERCK-CAPTOPRIL 25MG SANDOZ CAPTOPRIL 25MG ZAPTO 25MG TAB
CHRONIC RENAL FAILURE REGISTRATION CRITERIA: Diagnosis confirmed by a GP or Specialist Faxed copy of lab results required : serum creatinine clearance value
Medicine Price Monitor
Medicine Price Monitor Uganda No. 8 Jul-Sep 29 Medicine Price Monitor is supported by MEDICINE TRANSPARENCY ALLIANCE And published by UGANDA COUNTRY WORKING GROUP a collaboration of: MINISTRY OF HEALTH
Paroxetine 10mg Tab. does paroxetine cause high blood pressure. can you get high off of paroxetine hydrochloride
Paroxetine 10mg Tab does paroxetine cause high blood pressure can you get high off of paroxetine hydrochloride paroxetine hydrochloride hemihydrate msds paroxetine 40mg where can i buy paroxetine paroxetine
Hundreds of Choices. More Savings Every Day. 8 and $ 12 Generics Also Available. Based on 30-day supply at commonly prescribed doses
4$ Hundreds of Choices. More Savings Every Day. $ 8 and $ 12 Generics Also Available. Based on 30-day supply at commonly prescribed doses EFF. DATE 09/2017 List subject to change ALLERGIES, COLD AND FLU
Kyrgyzstan. Medicine prices, availability, affordability & price components
Kyrgyzstan Medicine prices, availability, affordability & price components Medicine prices matter Rapidly rising costs of health care and high medicine prices are a growing concern worldwide, especially
What if someone complains about me? A guide to the complaint process
What if someone complains about me? A guide to the complaint process Introduction The purpose of the licensed building practitioner scheme is to set performance standards for building practitioners and
1. Introduction. 2. Role of PSI as Pharmacy Regulator
1. Introduction 1.1. I would like to begin by thanking the Committee for inviting the Pharmaceutical Society of Ireland here today to assist in the Committee s on-going scrutiny of the Cannabis for Medicinal
Prevalence of chronic diseases in the population covered by medical aid schemes in South Africa
Prevalence of chronic diseases in the population covered by medical aid schemes in South Africa Research and Monitoring Unit June 2014 Chairperson: Prof. Y Veriava Chief Executive & Registrar: Dr M Gantsho
Riesbeck's Pharmacy Reward Club Generic Medication List October 2017
Allergy, Cold & Flu Antibiotic Treatments Arthritis & Pain Benzonatate 100mg cap 14 42 Diphenhydramine HCl Cap 50 MG 30 90 Diphenhydramine HCl Inj 50MG/ML 1 3 Diphenhydramine HCl Liquid 12.5 MG/5ML 720ml
Drug Typical Dose CrCl (ml/min) Dose adjustment for renal insufficiency Acyclovir PO (HSV) 400 mg TID >10 <10 or HD PD
Antimicrobial Dosing in Renal Insufficiency (Adults) ASP Handbook * In patients on hemodialysis (), give antimicrobial immediately after dialysis on dialysis days. = Intermittent hemodialysis = Peritoneal
Riesbeck's Pharmacy Reward Club Generic Medication List September 2017
Drug Category Allergy, Cold & Flu Antibiotic Treatments Arthritis & Pain Riesbeck's Benzonatate 100mg cap 14 42 Diphenhydramine HCl Cap 50 MG 30 90 Diphenhydramine HCl Liquid 12.5 MG/5ML 720ml 2160ml Hydroxyzine
Cardiovascular Drugs and Therapies HMG CoA a REDUCTASE INHIBITORS (available in Canada)
Trade Name Dosage Forms 10 mg, 20 mg, 40 mg, 80 mg tablets Dosing Range 10-80 mg once daily 2 Dosing Based on Desired LDL Reduction 1,2,3 HMG CoA a REDUCTASE INHIBITORS (available in Canada) LIPITOR, generics
MEDICINES CONTROL COUNCIL
MEDICINES CONTROL COUNCIL NOTIFICATION OF REGISTRATION OF MEDICINES BY THE REGISTRAR IN TERMS OF SECTION 17 OF THE MEDICINES AND RELATED SUBSTANCES ACT, 1965 (ACT 101 OF 1965) 42/2.5/0453 ZYDUS HEALTHCARE
Medicine Price. Monitor. for uganda. #12 July-September Ministry of. World Health organisation. Health Action International
Medicine Price Monitor for uganda #12 July-September 2014 Ministry of Health World Health organisation HEPS Uganda HAI AFRICA Health Action International MEDICINE PRICE MONITOR FOR UGANDA study team Survey
104 MMWR December 17, 2004
104 MMWR December 17, 2004 TABLE 8. Substantial pharmacokinetic drug-drug interactions for drugs used in the treatment of opportunistic Drugs Interacting with Mechanism/effects Recommendations Acyclovir
Home Delivery Prescription Program Drug List
Home Delivery Prescription Program Drug List Low-cost prescriptions, right in your mailbox. Now you can have your generic prescriptions mailed right to your home, no matter where you live. Because we think
90-Day Generic Drug Discount List Treatment Medication Strength Dose Quantity Price Allergy/Cold&Flu Benzonatate 100mg Tablet 42 $15.
90-Day Generic Drug Discount List Treatment Medication Strength Dose Quantity Price Allergy/Cold&Flu Benzonatate 100mg Tablet 42 $15.00 Allergy/Cold&Flu C-Phen Drops n/a Drops 90 $15.00 Allergy/Cold&Flu
HOW TO LodgE a complaint against a
HOW TO LodgE a complaint against a healthcare practitioner Protecting the public and guiding the professions Good health is your right All people have the right to good health and quality healthcare. This
MEDICINES CONTROL COUNCIL
MEDICINES CONTROL COUNCIL NOTIFICATION OF REGISTRATION OF MEDICINES BY THE REGISTRAR IN TERMS OF SECTION 17 OF THE MEDICINES AND RELATED SUBSTANCES ACT, 1965 (ACT 101 OF 1965) 41/20.1.1/0039 SCP MYLAN
YES = formulary NO = non-formulary NO BENEFIT = excluded
Benefits are subject to the following: Pre-authorisation Bestmed guidelines Bestmed protocols Mediscor Reference Price (MRP) This price represents the reasonable price in the market place for a particular
NEXIUM INTRAVENOUS esomeprazole sodium
NEXIUM INTRAVENOUS esomeprazole sodium Consumer Medicine Information What is in this leaflet This leaflet answers some of the common questions people ask about NEXIUM Intravenous (IV). It does not contain
Ontario Drug Benefit Formulary/Comparative Drug Index
Ministry of Health and Long-Term Care Ontario Drug Benefit Formulary/Comparative Drug Index Edition 43 Summary of Changes August 2018 Effective August 30, 2018 Drug Programs Policy and Strategy Branch
MEDICINES CONTROL COUNCIL
MEDICINES CONTROL COUNCIL NOTIFICATION OF REGISTRATION OF MEDICINES BY THE REGISTRAR IN TERMS OF SECTION 17 OF THE MEDICINES AND RELATED SUBSTANCES ACT, 1965 (ACT 101 OF 1965) 08/3.1.2/14 INGELHEIM A39/34/0605
MEDICINES CONTROL COUNCIL
MEDICINES CONTROL COUNCIL NOTIFICATION OF REGISTRATION OF MEDICINES BY THE REGISTRAR IN TERMS OF SECTION 17 OF THE MEDICINES AND RELATED SUBSTANCES ACT, 1965 (ACT 101 OF 1965) A05/11.5/08 A38/20.1.1/0406
NB Drug Plans Formulary Update
Bulletin #915 October 30, 2015 NB Drug Formulary Update Please find attached a list of generic drug product updates for the New Brunswick Drug Formulary. Generic drug product additions New generic products
VMG Pharmaceuticals Pvt. Ltd.
S. No. Product Name S trength Dos age form Oncology 1 A nastrazole 1 mg Tablets 2 Bicalutamide 50 mg Tablets 3 Bleomycin 15units,30units Injection 4 Bortezomib 3.5 mg Injection 5 Capecitabine 500 mg Tablets
Patient information leaflet. A study of low dose theophylline in Chronic Obstructive Pulmonary Disease (COPD)
Patient information leaflet A study of low dose theophylline in Chronic Obstructive Pulmonary Disease (COPD) Theophylline With Inhaled CorticoSteroids (TWICS) study. We would like to invite you to take
Chronic Illness Benefit Application form 2018
Chronic Illness Benefit Application form 2018 Contact us Tel (Members): 0860 99 88 77, Tel (Health partners): 0860 44 55 66, PO Box 784262, Sandton, 2146, www.discovery.co.za. Who we are Discovery Health
Agents for Cystic Fibrosis
Texas Prior Authorization Program Clinical Edit Criteria Clinical Edit Information Included in this Document Kalydeco (Ivacaftor) Drugs requiring prior authorization: the list of drugs requiring prior
Recommendations: Agend a no. Recommendations. Institute. New Drugs Division /12-DC ArbekacinSulphate Injection 200mg/4ml
: I approve the minutes of 32 nd SEC (Antimicrobial, Antiviral, Antiparasitic and Antifungal) held on 11.04.2017 at CDSCO HQ New Delhi and recommended the following: Agend New Drugs Division 1 12-34/12-DC
UPDATE B Ontario Drug Benefit Formulary/Comparative Drug Index No. 41 Effective October 01, 2008 SUMMARY OF CHANGES
UPDATE B Ontario Drug Benefit Formulary/Comparative Drug Index No. 41 Effective October 01, 2008 SUMMARY OF CHANGES TABLE OF CONTENTS Page New Multi-Source Drug(s) 2 Manufacturer Requested Discontinued
Tunisia. Medicine prices, availability, affordability and price components. Medicine prices matter. Tunisia
prices, availability, affordability and price components prices matter Rapidly rising costs of health care and high medicine prices are a growing concern worldwide, especially in developing and transitional
The South African Depression and Anxiety Group (SADAG) Competition Commission: Market Inquiry into the Private Healthcare Sector
The South African Depression and Anxiety Group (SADAG) Competition Commission: Market Inquiry into the Private Healthcare Sector Introduction SADAG is registered NGO since 1994 Leading Mental Health Advocacy
2017 Bankmed Personal Health Assessment (PHA) and HIV/AIDS Counselling and Testing (HCT) Provider Manual
2017 Bankmed Personal Health Assessment (PHA) and HIV/AIDS Counselling and Testing (HCT) Provider Manual Bankmed Personal Health Assessment and HIV/AIDS Counselling and Testing Handbook 2017 The World
Kuwait. Medicine prices, availability, affordability and price components. Medicine prices matter
prices, availability, affordability and price components prices matter Rapidly rising costs of health care and high medicine prices are a growing concern worldwide, especially in developing and transitional
UPDATE AA Ontario Drug Benefit Formulary/Comparative Drug Index No. 41 Effective September 15, 2011 SUMMARY OF CHANGES
UPDATE AA Ontario Drug Benefit Formulary/Comparative Drug Index No. 41 Effective September 15, 2011 SUMMARY OF CHANGES TABLE OF CONTENTS Page New Single Source Drug(s) 2 New Multi-Source Drug(s) 3 Off
MIDAZOLAM APOTEX Solution for Injection Contains the active ingredient midazolam
MIDAZOLAM APOTEX Solution for Injection Contains the active ingredient midazolam Consumer Medicine Information For a copy of a large print leaflet, Ph: 1800 195 055 What is in this leaflet Read this leaflet
Ontario Drug Benefit Formulary/Comparative Drug Index
Ministry of Health and Long-Term Care Ontario Drug Benefit Formulary/Comparative Drug Index Edition 42 Summary of Changes September 2017 Effective September 28, 2017 Drug Programs Policy and Strategy Branch
the best of care Managing diabetes with the FORA Diamond MINI and tools from Discovery Health Medical Scheme
the best of care 2014 Managing diabetes with the FORA Diamond MINI and tools from Discovery Health Medical Scheme contents What this document is about This document gives an overview of the FORA Diamond
SASKATCHEWAN FORMULARY COMMITTEE BULLETIN TO THE 58th EDITION OF THE SASKATCHEWAN FORMULARY
Saskatchewan Ministry of Health Drug Plan and Extended Benefits Branch July 2008 Bulletin #115 ISSN 0708-3246 SASKATCHEWAN FORMULARY COMMITTEE BULLETIN TO THE 58th EDITION OF THE SASKATCHEWAN FORMULARY
Subcutaneous Rituximab with or without Ibrutinib, Maintenance Period - ENRICH Study
Subcutaneous Rituximab with or without Ibrutinib, Maintenance Period Study Randomised, open label study of Rituximab/Ibrutinib vs Rituximab/Chemotherapy in older patients with untreated mantle cell lymphoma
PATIENT INFORMATION LEAFLET DYNAFIL RANGE
Scheduling Status: S4 Proprietary name, Strength and Pharmaceutical Form: DYNAFIL 25 mg (coated tablets) DYNAFIL 50 mg (coated tablets) DYNAFIL 100 mg (coated tablets) Please read this leaflet carefully
TAILOR-MADE ALWAYS A BETTER FIT
Unique and Tailored Benefits Emotional Wellness Support Excellent Infertility Benefits Minimum of 27 Chronic Conditions Covered No General Waiting Period Unlimited Oncology Benefits Peace of Mind TAILOR-MADE
Ontario Drug Benefit Formulary/Comparative Drug Index
Ministry of Health and Long-Term Care Ontario Drug Benefit Formulary/Comparative Drug Index Edition 42 Summary of Changes June 2017 Effective June 29, 2017 Drug Programs Policy and Strategy Branch Ontario
CNHC Guidance on The Cancer Act (Please note this does not constitute legal advice)
CNHC Guidance on The Cancer Act 1939 (Please note this does not constitute legal advice) 1. Introduction 1.1. In November 2012 CNHC produced Advertising Guidance to support CNHC registered practitioners
Medicine Price Monitor
Medicine Price Monitor Uganda No. 9 Apr-Jun 21 Medicine Price Monitor is supported by MEDICINE TRANSPARENCY ALLIANCE And published by UGANDA COUNTRY WORKING GROUP a collaboration of: MINISTRY OF HEALTH
I M REGISTERED. Promoting your status as a registered health professional. A guide for osteopaths
I M REGISTERED Promoting your status as a registered health professional A guide for osteopaths 2 Why is it important for me to raise awareness of my registration? Patients want to be assured that you
ASMI COMPLAINTS PANEL FINAL DETERMINATION Meeting held May 11, 2010
ASMI COMPLAINTS PANEL FINAL DETERMINATION Meeting held May 11, 2010 Wyeth Consumer Healthcare Pty Limited ( Wyeth ) v. Bayer Australia Limited ( Bayer ) Citracal promotional claims. 1. Wyeth complains
CSSIW Participation Plan. Working Together to Improve Social Care Services
CSSIW Participation Plan Working Together to Improve Social Care Services Printed on recycled paper Print ISBN 978 0 7504 8280 6 Digital ISBN 978 0 7504 8281 3 Crown copyright 2012 WG16698 Introduction
Unit 204 Assist with the assembly of prescribed items
Element 1 Assemble prescribed 171 172 Element 1 Assemble prescribed Background Assembling prescribed is a complex process. The two main components of this process are labelling and dispensing. It is essential
Effective for all members on November 1, 2017
November 2017 Pharmacy Formulary Change Notice BlueChoice HealthPlan Medicaid is here to help you stay on top of your health care. We want to tell you about some upcoming changes to your Preferred Drug
ACNE - SEVERE. Pace4 Pace3 Pace2 Pace1 Beat 4 Beat3. Pace4 Pace3 Pace2 Pace1 Beat 4 Beat3 MEDICINE NAME MEDICINE NAME
ACNE - SEVERE Pace Beat 4 Beat3 Pace Beat 4 Beat3 A ACNETANE 0 CYCLIDOX EC 00MG CAP ACNETANE 20 CYCLIMYCIN 00MG CAP ADCO-CO-TRIMOXAZOLE CYCLIMYCIN 50MG CAP ADCO-ERYTHROMYCIN 250 CAP CYPRENE-35 ED TAB ADCO-FEM
Package leaflet: Information for the patient. SIRTURO 100 mg tablets Bedaquiline
Package leaflet: Information for the patient SIRTURO 100 mg tablets Bedaquiline This medicine is subject to additional monitoring. This will allow quick identification of new safety information. You can
Nova Scotia Pharmacare Programs Interchangeable Product Updates November 13, 2018 New Categories
PAGE 1 OF 7 Nova Scotia Pharmacare Programs Interchangeable Product Updates November 13, New Categories A Maximum Reimbursable Price (MRP) or Pharmacare Reimbursement Price (PRP) has been established for
REGISTRATION CRITERIA : SPECIALIST INITIATION OF TREATMENT AND FOR ANY SIGNIFICANT INCREASES IN DOSAGES OR ADDITION OF MEDICATION.
CARDIOMYOPATHY REGISTRATION CRITERIA : SPECIALIST INITIATION OF TREATMENT AND FOR ANY SIGNIFICANT INCREASES IN DOSAGES OR ADDITION OF MEDICATION. * REQUEST FOR ANGIO-TENSIN RECEPTOR BLOCKER WILL REQUIRE
SASKATCHEWAN FORMULARY BULLETIN Update to the 60th Edition of the Saskatchewan Formulary
Saskatchewan Ministry of Health November 1, 2010 Drug Plan and Extended Benefits Branch Bulletin #126 ISSN 1923-077X SASKATCHEWAN FORMULARY BULLETIN Update to the 60th Edition of the Saskatchewan Formulary